NCT01524926 2023-12-11CREATEEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed582 enrolled
NCT01742286 2020-06-09Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)NovartisPhase 1 Completed83 enrolled 30 charts